The Impact of the Falsified Medicines Directive in the Dispensing Operations of an Austrian Hospital Pharmacy [PDF]
Journal of Hospital & Medical Management, 2017 The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) will need to be implemented in the next couple of years to ensure compliance of dispensing operations in the secondary environment. This study was developed in an Austrian hospital, using a medicines authentication system to assess the impact of the implementation of the legal ...
de Pinto, CN +4 more
openaire +4 more sources
Medicine Shortages: From Assumption to Evidence to Action - A Proposal for Using the FMD Data Repositories for Shortages Monitoring [PDF]
Frontiers in Medicine, 2021 Medicine shortages may negatively impact patient care and the patient experience. Shortages should be a priority of industry, supply chain stakeholders and national competent authorities, and deserve more than empathy or “lip-service” but serious ...
François Bouvy, Mihai Rotaru
doaj +2 more sources
Implementing the EU Falsified Medicines Directive [PDF]
The Prescriber, 2019 The European Union's Falsified Medicines Directive, which came into force on 9 February, has laid down rigorous rules for pharmaceutical companies and pharmacists to follow in a bid to eradicate the pernicious impact of fake drugs infiltrating the legal supply chain. Joy Ogden reports on the progress so far.
exaly +2 more sources
EAHP President Joan Peppard advises members to heighten their awareness of the Falsified Medicines Directive in 2016. [PDF]
Eur J Hosp Pharm, 2016 Writing to national member associations, EAHP President Joan Peppard has encouraged hospital pharmacists in all EU and European Economic Area (EEA) countries to take time to familiarise themselves with the forthcoming impacts to practice arising from the 2011 Falsified Medicines Directive and ensure hospital pharmacy representation at the national ...
Price R.
europepmc +4 more sources
Fighting Counterfeit Medicines in Europe: The Effect on Access to Medicines
Medicine Access @ Point of Care, 2017 The implementation of the Falsified Medicines Directive, and its Delegated Regulation with detailed specifications of safety features, will provide an additional obstacle for counterfeiters.
Maarten Van Baelen +5 more
doaj +3 more sources
European Directive on Falsified Medicines: Lights and shadows for the Hospital Pharmacy [PDF]
Farmacia Hospitalaria, 2018 Ana Herranz, Eva Negro
doaj +3 more sources
Brexit and the falsified medicines directive [PDF]
, 2017 In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user ...
Hibberd, Ralph
core +5 more sources
Introduction of Good Practices of Drug Verification (DPWL) in hospital practice in Poland in order to protect against counterfeit drugs and improve patient safety [PDF]
Farmacja Polska, 2020 The phenomenon of counterfeit medicines is common in healthcare systems around the world, making it a global problem. The number of recorded cases of falsified drugs available on the market is increasing every year.
Piotr Merks +2 more
doaj +1 more source
Falsified drugs as a challenge to public health - an attempt to define the concept and scale of the phenomenon in the world as well as legal and sociological approach [PDF]
Farmacja Polska, 2019 The below article is a review regarding sociological and factual context of the implementation of Falsified Medicine Directive with a particular focus on Poland.
Damian Świeczkowski +3 more
doaj +1 more source
Cardiology Journal, 2022 Valsartan, losartan, and irbesartan, are widely used in the treatment strategies of cardiovascular medicine diseases, including hypertension and heart failure.
Damian Świeczkowski +5 more
doaj +1 more source